Liensinine diperchlorate and artemisitene synergistically attenuate breast cancer progression through suppressing PI3K-AKT signaling and their efficiency in breast cancer patient-derived organoids-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liensinine diperchlorate and artemisitene synergistically attenuate breast cancer progression through suppressing PI3K-AKT signaling and their efficiency in breast cancer patient-derived organoids

Published:2024-07 Issue: Volume:176 Page:116871
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Lin Xian,Lin Tengyu,Liu Meng,Chen Dong,Chen Jian^ORCID

Publisher

Elsevier BV

Reference37 articles.

1. Cancer statistics in China and United States, 2022: profiles, trends, and determinants;Xia;Chin. Med J. (Engl. ),2022

2. Oxypalmatine regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids;Lin;Phytomedicine,2023

3. PI3K-AKT-Targeting Breast Cancer Treatments: natural products and synthetic compounds;Yuan;Biomolecules,2023

4. Xanthotoxol suppresses non-small cell lung cancer progression and might improve patients' prognosis;Lin;Phytomedicine,2022

5. Liensinine perchlorate inhibits colorectal cancer tumorigenesis by inducing mitochondrial dysfunction and apoptosis;Wang;Food Funct.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP